Skip to main content

CYTOKINETICS INC

For the period ended Mar 31, 2026. Filed May 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 5, 2026

CYTK$56.18+1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

(In thousands) (Unaudited)

Three Months Ended
March 31, 2026March 31, 2025
Cash flows from operating activities:
Net loss$(206,031)$(161,376)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense on liabilities related to revenue participation right purchase agreements18,81614,104
Stock-based compensation expense30,39423,549
Non-cash lease expense1,5851,230
Depreciation of property and equipment3,3782,300
Change in fair value of derivative liabilities(1,500)400
Change in fair value of liabilities related to RPI Transactions1,600(3,900)
Realized gain on investment, net(61)—
Interest receivable and amortization on investments(1,874)(6,174)
Non-cash interest expense related to debt8,4553,453
Changes in operating assets and liabilities:
Accounts receivable10,93714,638
Prepaid and other assets2,057(376)
Inventories(3,567)—
Accounts payable1,519(4,576)
Deferred revenue41—
Accrued and other liabilities(6,213)(14,367)
Operating lease liabilities(1,039)(2,143)
Other non-current liabilities(3,954)1,621
Net cash used in operating activities(145,457)(131,617)
Cash flows from investing activities:
Purchases of investments(106,516)(159,105)
Investment in non-marketable equity security—(5,000)
Maturities of investments257,938275,725
Purchases of property and equipment(5,930)(5,664)
Net cash provided by investing activities145,492105,956
Cash flows from financing activities:
Repayment of finance lease liabilities—(202)
Repayment of term loans(2,735)(2,682)
Proceeds from issuance of common stock under equity incentive and stock purchase plans11,3467,651
Taxes paid related to net share settlement of equity awards(841)(13)
Net cash provided by financing activities7,7704,754
Effect of exchange rate changes on cash(483)(270)
Net increase (decrease) in cash, cash equivalents, and restricted cash7,322(21,177)
Cash, cash equivalents, and restricted cash, beginning of period125,63295,232
Cash, cash equivalents, and restricted cash, end of period$132,954$74,055
Supplemental cash flow disclosures:
Cash paid for interest$1,585$9,647
Non-cash investing and financing activities:
Right-of-use assets recognized in exchange for operating lease obligations$170$3,501
Amounts unpaid for purchases of property and equipment$4,186$1,494
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.